SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001023024-23-000029
Filing Date
2023-10-02
Accepted
2023-10-02 07:04:51
Documents
19
Period of Report
2023-10-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20231002.htm   iXBRL 8-K 29067
2 EX-99.1 exhibit991pressrelease10.htm EX-99.1 15394
6 exhibit991pressrelease10001.jpg GRAPHIC 146433
7 exhibit991pressrelease10002.jpg GRAPHIC 223615
8 exhibit991pressrelease10003.jpg GRAPHIC 188012
9 exhibit991pressrelease10004.jpg GRAPHIC 202828
10 exhibit991pressrelease10005.jpg GRAPHIC 280334
11 exhibit991pressrelease10006.jpg GRAPHIC 42398
  Complete submission text file 0001023024-23-000029.txt   1669250

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20231002.xsd EX-101.SCH 1874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20231002_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20231002_pre.xml EX-101.PRE 12491
13 EXTRACTED XBRL INSTANCE DOCUMENT ani-20231002_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 231297697
SIC: 2834 Pharmaceutical Preparations